在皮肤和血清特定IgE过敏测试后,医疗保健利用率和结果的比较
Yang Z Lu1, Kenny Yat-Choi Kwong2
1Department of Health Care Administration, California State University Long Beach, Long Beach, CA, USA.
Journal of medical economics
|April 29, 2024
概括
血清特异性IgE (sIgE) 过敏测试比皮肤测试更具成本效益,导致过敏学家的访问减少,并减少紧急护理的利用率. 这两种方法都在一年内减少了急诊和紧急护理访问.
科学领域:
- 过敏的诊断 过敏的诊断
- 卫生经济学 卫生经济学
- 临床结果研究研究的临床结果.
背景情况:
- 过敏测试对于诊断过敏状况至关重要.
- 对比不同过敏测试方式的成本效益和临床效用,对于优化患者护理和资源配置至关重要.
研究的目的:
- 为了比较皮肤刺探测试与血清特异性IgE (sIgE) 测试的成本,医疗保健利用率和相关结果.
- 评估不同过敏测试方法对患者管理和医疗保健资源使用的长期影响.
主要方法:
- 使用IBM MarketScan索赔数据 (2018-2019) 进行的回顾性队列研究.
- 包括经过过敏测试的商业保险人员,包括12个月的指数前和后测试数据.
- 分析测试成本,医疗保健利用 (办公室访问,处方,ED / UC访问) 和使用多变量回归的结果.
主要成果:
- 血清特异性IgE (sIgE) 测试与皮肤测试 (430美元/患者) 或组合测试 (532美元/患者) 相比,成本显著降低 (187美元/患者).
- 过敏测试模式与急诊室 (ED) 和紧急护理 (UC) 访问 (10.9-17.4%) 的显着减少有关,在1年的随访中.
- 与仅用皮肤测试相比,仅用sIgE测试的患者对过敏学家/免疫学家的访问较少 (3.2次少),整体医疗保健利用率和结果相似.
结论:
- 过敏检测,无论采用哪种方法,都能在一年内减少ED和UC的访问.
- 血清特异性IgE (sIgE) 过敏测试是一个更具成本效益的选择,与传统皮肤测试相比,与更少的专家咨询有关.
关键词:
一个小小的东西.A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1 A1A1010 A1010 A1010 A1010 A1010 A1010 A1010 A1010 A1010 A1010 A1010 A1010 A1010 A1010 A1010 A1010 A10 A10 A10 A10 A10 A10 A10 A10过敏测试 过敏测试 过敏测试D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D 在线观看 在线观看 在线观看 在线观看D00 D00 D00 D00 D00 D00 D00 D00 D00 D00 D00 D00 D00 D00 D00我已经开始了,我已经开始了.第111章 这是一件好事一千一百零一年 一百一十年费用 费用 费用 费用 费用健康结果的健康结果.医疗保健利用率 医疗保健利用率一个回顾性队列队列.皮肤刺痛的刺痛特定-IgE 的情况.相关概念视频
Allergic Reactions
Overview
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...


